|
Glycemic Control Data
Show Improvement in Glucose Levels
Journal of
Hospital Medicine, December 2012
New data show that hospitals may be making some progress
in the battle to control glucose levels in non-ICU
patients. Research published in the Journal of Hospital
Medicine compared point-of-care blood glucose test
results from 126 hospitals taken in 2007 and 2009. The
values of those test results decreased by 5 mg/dL in
non-ICU patients from 2007-2009, but remained unchanged
for patients in the ICU.
In this first analysis of glucose changes in US
hospitals, improvements over 2 years occurred in non-ICU
patients. Ongoing analysis will determine whether this
trend continues.
Read more. |
|
Understanding Low Sugar from
NICE-SUGAR
The New
England Journal of Medicine, December 2012
In his editorial about the Normoglycemia in Intensive
Care Evaluation–Survival Using Glucose Algorithm
Regulation (NICE-SUGAR) study, Hirsch (Sept. 20 issue)
declares, “For surgical patients, especially those who
have undergone cardiac procedures, hospitals that can
safely achieve lower targets should do so.” No
justification for this statement is provided. Concerns
exist regarding the generalizability of studies of
glycemic control in other populations of patients
treated in intensive care units (ICUs) that have shown
either harm1 or no benefit and regarding both the
generalizability and applicability of studies that have
shown benefit.
Read more. |
|
Glucose in the ICU —
Evidence, Guidelines, and Outcomes
The New
England Journal of Medicine, December 2012
Agus et al. (Sept. 27 issue)1 report that targeting a
blood glucose level of 80 to 110 mg per deciliter (4.4
to 6.1 mmol per liter) in critically ill infants and
toddlers (<3 years of age) after cardiac surgery did not
alter the clinical outcome. Although the target range
for the blood glucose level was “normal” in fasting
adults, it indicated
hyperglycemia in infants (normal range, 50 to 80 mg per
deciliter [2.8 to 4.4 mmol per liter]).
Read more. |
|
Connecting With POCT
By Adetoun
Ejilemele, MB.CHB, FWACP, FMCPath (Nig), and Anthony O.
Okorodudu, PhD, MBA, DABCC, FACBB
Point-of-care
testing plays a significant role in a value-based
purchase system Value-based purchasing (VBP)
is focused on ensuring synchrony between clinical and
financial responsibilities in our healthcare systems. In
the VBP, future healthcare payment is linked to quality
and efficiency of the care provided. This
article was part of the Advance for Administrators of
the Laboratory's December 2012 issue which feature a
2013 Resource Directory. For more on this article and to
view the digital edition,
click here > |
|
Article
Archive
FDA clears ACCU-CHEK
Inform II
Roche’s new hospital point-of-care system for blood
glucose testing with improved accuracy and wireless data
transfer as well as advances in patient care and
durability. Roche announced on Monday, October 15, that
it has received clearance from the U.S. Food and Drug
Administration (FDA) for the ACCU-CHEK Inform II system,
a next-generation blood glucose monitor for hospital
point-of-care testing. The ACCU-CHEK Inform II system
offers healthcare professionals the first truly wireless
hospital blood glucose device. The system utilizes new
patented technology to deliver improved accuracy and
enables automatic real-time wireless transfer of patient
data between hospital medical staff and the laboratory.
“Accuracy and patient safety are the foremost concerns
for blood glucose testing in hospitals and other
point-of-care settings,” said Roland Diggelmann, chief
operating officer at Roche Diagnostics. “ACCU-CHEK
systems have been proven in hospitals around the world
and this next-generation wireless system sets a new
standard by offering U.S. healthcare professionals new
capabilities to help ensure the accuracy of test
results, streamline data communications and provide
optimal patient care.”
The Growth of
Point-of-Care Testing in Hospitals
Cardiac Markers Fuel Growth in $5 Billion Market
Hospital point-of-care (POC) testing continues to
grow steadily, with hospitals adding more instruments
and rapidly increasing the volume of cardiac testing in
particular, according to a new report from strategic
consulting firm Enterprise Analysis Corporation (EAC).
This brief analyzes data from a 2011 survey of hundreds
of hospital-based point-of-care coordinators (POCC), and
compares data to the company’s previous survey in 2007.
While POC glucose, blood gas, coagulation, and HbA1c
tests have seen a slow, steady rise over the past 4
years, cardiac marker testing has risen sharply,
according to EAC senior consultant Michelle Keane. “We
were surprised to find 10 percent more hospitals
performing cardiac marker testing compared to 2007, and
volumes have increased significantly as well,” Keane
commented. For stand-alone troponin, nearly twice as
many hospitals surveyed by EAC now perform POC testing.
Two instruments continue to dominate the cardiac
marker POC market, Abbott’s i-STAT system and Alere’s
Triage system. The Triage has seen a 70% increase in
volume for cardiac tests, and i-STAT’s volumes have
tripled.
Keane also noted that POC has become more complex in
hospitals, with 23% of institutions reporting use of six
or more different POC instruments in 2011 compared to
just 5% in 2007. Nearly 50% of hospitals EAC surveyed
now have four or more instruments.
Spotlight on
Point-of-Care Testing
Innovation, Expansion Evident at AACC Clinical Lab Expo
in LA
By Bill Malone, Clinical Laboratory News
The current issue of CLN features a Spotlight on the
2012 AACC Meeting where more than 120 companies came to
Los Angeles to showcase POC products at the AACC
Clinical Lab Expo, and the buzz about POC spilled over
into sessions at the AACC Annual Meeting. Speakers
covered many POC topics, including the explosion of
technology and where future opportunities lie. This
issue also includes an interview with the 2012 POCC of
the Year Pet Maniquis. In addition, hundreds of new
products made their debut in Los Angeles and are
highlighted in CLN's New Products Review. More >
Note: To access this issue you must be an AACC member -
and now is great time to join and take advantage of all
the POC related programs AACC and the Critical and
Point-of-Care Testing Division have to offer.
Abbott Introduces Advanced Quality Features on its i-STAT
Handheld System
Abbott has introduced five new advanced quality features
on its leading i-STAT handheld blood analyzer, designed
to help hospitals better manage their point-of-care
testing programs and ensure compliance with changing
laboratory regulations. The i-STAT Advanced Quality
Features will help organizations improve compliance,
oversight and control of their point-of-care program.
A
Review of Tight Glycemic Control
more >
Assessing Inpatient Glycemic Control: What
Are the Next Steps?
Which Metric Should
be Used? more >
Glucose Meter Update Lifescan customers, follow these tips to
smooth your transition to a new meter
more >
Update on Inpatient Glycemic Control in Hospitals in the
United States
Many quality improvement organizations have been
focusing on improving the management of inpatient
hyperglycemia. A recent survey of hospitals in the
United States demonstrated that the frequencies of
hypoglycemia and hyperglycemia were the top 2 metrics of
interest to hospitals, and many hospitals have either
fully or at least partially implemented inpatient
diabetes quality improvement programs. Several quality
improvement organizations are promoting the need for
better inpatient glycemic control and have developed
educational resources to help hospitals achieve better
management. Finally, in certain clinical scenarios,
better glucose control has been shown to improve patient
outcomes.
more >
The Evolving World of POCT
more >
Focus on: COAGULATION Monitoring
more >
Panel Advises Glucose Testing in All
Hospitalized Patients
More >
Diabetes Cases Double to 347 Million
Rates of diabetes have nearly tripled in the U.S., and
more than doubled worldwide since 1980, according to a
report this week in the British journal Lancet. More
than 347 million patients have diabetes globally, and
nearly 25 million in the U.S..
more >
References for "Urine
Drug-of-Abuse Testing in
the Clinical Lab"
By Jill
Hoffman, Advance for the Administrators of the
Laboratory
According to a 2009 review in Bioanalysis, use of
clinical urine drug tests (UDTs) to monitor patients
prescribed controlled substances is a new aspect of
clinical medicine that will play an increasing role as
physicians treat chronic pain while trying to minimize
abuse of opioid analgesics.
more >
Glucose Meter Evolution
By Bob
Kaplanis, Advance for the Administrators of the
Laboratory, At the Bedside
It's hard to imagine what point-of-care testing (POCT)
would be like if the glucose meter had never been
invented and all glucose testing was performed in the
main laboratory of the hospital.
more >
Testing/Diagnostics:
Point Taken
Clinical Lab Products - July
2011by Sarah Michaud
Overview of point-of-care testing, technological
challenges, and future opportunities.
Point-of-care testing (POCT) technology provides
immediate, portable, and convenient medical diagnostics
near the site of patient care. POCT's near-instantaneous
results allow health care providers to make treatment
decisions for their patients in a shorter amount of time
compared to traditional laboratory diagnostics. Faster
test results translate to rapid treatment for
patients—which can save lives in critical care
scenarios.
More >
Glucose Monitoring
Technology
By Jill Hoffman, ADVANCE for
Administrators of the Laboratory; June 6, 2011
Blood
glucose monitoring evaluates the concentration of
glucose in blood and is a critical component of diabetes
mellitus care. Tests are performed by piercing the skin
to draw and apply blood to a chemically active test
strip. Small handheld devices-glucometers-can measure
blood glucose. To get accurate readings, it is important
to make sure the glucose meter is operating correctly by
applying quality control (QC) material to the strip,
often sold separately for home glucometers, says
Frederick L. Kiechle, MD, PhD, director of Clinical
Pathology, Pathology Consultants of South Broward,
Memorial Healthcare System, Hollywood, FL.
more >
POC Coag Technology Path: Simple to Savvy
CAP
Today, May 2011, by Brendan Dabkowski
Smart businesses stick to the principle that the
customer is always right. For manufacturers of
point-of-care coagulation test systems, whose customers
are often now individual patients, keeping that
principle top of mind is imperative. Offering test
systems that help ensure customers/ patients are
right—that is, in obtaining accurate coagulation
status—protects lives.
more > I
See CAP TODAY’s
coagulation analyzers lineup
The
Growth of POCT
By Carlos Prieto-Granada, MD, and
James H. Nichols, PhD, DABCC, FACB March 2011 • advance/Laboratory
The development of newer technologies and overall
improvement of POCT quality has led to an exponential
growth in the POCT field. As an emerging,
rapidly evolving and ever expanding specialty in
laboratory medicine, point-of-care testing (POCT) has
been generating a whole new set of issues since its
popularization in the late 1980s. Tconcept of POCT,
also known as bedside, near-patient testing and
decentralized testing, relates to tests that are
conducted by clinical operators at the site of patient
care where immediate medical action is taken on the
results.
The fact that POCT represents a departure from
conventional laboratory medicine has created new
challenges, especially regarding standardization and
regulation. These topics, including new regulatory
changes, glucose meter performance criteria and
increasing reliance on transcutaneous POCT methods, are
addressed.
more >
Preventing Medical Errors
RFID technology helps identify patient, hardware and
staff locations, as well as preventable gaps in care.
By Mayank
Trivedi, April 2011 • advance/Laboratory
More than 10 years after the publication of "To Err is
Human," few hospitals have successfully heeded the call
to cut down the number of fatal medical errors in the
United States.
The failure certainly is not due to lack of effort or
commitment. Hospitals have published innumerable
studies, protocols, and analysis to improve patient
safety. But the results have too often fallen short.
With increasing clinical workloads and cost pressures,
many healthcare organizations have begun to investigate
how technologies such as radiofrequency identification (RFID)
tags, which "sense" staff and asset locations, can
enhance clinical and biomedical workflow. RFID
technology can track the physical location of patients,
staff, equipment, as well as instruments and
pharmaceuticals, helping to increase patient safety.
This technology can reduce medical errors in a number of
ways.
More >
Accuracy above all for POC glucose analyzers -
See CAP TODAY’s glucose analyzers lineup
By Brendan
Dabkowski, CAP Today, March 2011
Makers of
point-of-care glucose testing systems are responding to
customers’ demands for devices that are nimble,
responsive, and durable—but above all, accurate.
“Hospitals continue to demand improved accuracy of
bedside glucose monitors as they adopt protocols for
better glycemic management,” says Nova Biomedical
marketing specialist Rick Rollins.
more >
10
years out, Connectivity Standard Still not in
CAP Today, February 201,
Feature Story, by Anne Ford
By their first birthday, most babies show signs of
dental development. But the point-of-care connectivity
standard POCT1-A celebrates its 10th anniversary this
year, and some say it has yet to start growing teeth.
That is, the standard
has no enforcing body, and so adoption has been left up
to individual vendors, some of whom are not inclined to
spend financial resources making their legacy systems
compliant with POCT1A.
More >
Too far, Too Fast on ICU TGC?
CAP
Today, March 2011, Feature Story, by Anne Paxton
Ten years
ago, a study conducted in Leuven, Belgium, took U.S.
hospital intensive care units by storm. Reported in
the New England Journal of Medicine, the trial, led by
Greet Van den Berghe, MD, PhD, found that when adult
surgical ICU patients’ blood glucose was maintained
between 80 and 110 mg/dL by means of an insulin
infusion, it reduced ICU mortality by 42 percent and
in-hospital mortality by 34 percent
(2001;345:1359–1367). Implementing an ICU protocol of
tight glycemic control, the study concluded, also
decreased the incidence of acute renal failure,
septicemia, and critical illness polyneuropathy.
These
conclusions galvanized hospital ICUs. In the wake of
the study, “Intensive care units in the U.S. went from
almost nobody using insulin to using it on almost every
patient,” says Stanley A. Nasraway, MD, director of the
surgical intensive care units at Tufts Medical Center,
Boston. As one indicator of the impact on laboratory
testing, Barnes Jewish Hospital in St Louis, Mo.,
doubled the number of glucose strips it consumes.
“In
2001, we used 250,000 strips a year and we’re at almost
half a million strips a year now, just with essentially
the same number of beds,” says Mitchell G. Scott, PhD,
professor of pathology and immunology and co-medical
director of clinical chemistry at Washington University
School of Medicine.
But as tight glycemic control (TGC) became more and
more the standard for adult patients across the critical
care landscape in the U.S., there were ripples of
concern. Efforts to duplicate the Leuven study did
not all pan out. One of Dr. Van den Berghe’s own later
studies in medical ICU patients showed only morbidity
benefits. Then, two large-scale studies in 2008 and 2009
suggested that, in fact, very tight glycemic control may
actually put patients at greater risk of death and
complications from hypoglycemia.
more >
Selecting
Point-of-Care Devices
Direct patient care professionals are looking
for rapid testing
options to accelerate diagnoses and
treatment plans.
By Ginger A. Baker, MS, MT(AAB),
Posted: January 2011, ADVANCE for Medical Laboratory
Professionals
The point-of-care (POC) test and device market has been
one area with sustained growth, even in a difficult
economic climate. This sector has sustained a 7.5
percent annual growth. Additionally, with the need to
reach a diagnosis and treatment plan as quickly as
possible, direct patient care professionals are looking
for rapid POC testing options. Both factors polarize
vendor focus on the POC market. The test options can
seem endless at times. In this installment of "At the
Bedside," a few key questions and considerations are
recommended.
Meeting Electronic Records Needs
Like laboratory
instruments, POC devices are not all created equal. Each
has enhanced options or methodologies that set it apart
from the market. The real trick is knowing what
information to target and what questions to ask. With
the coming HITECH requirements, it is probable that all
devices will need to be interfaced to the electronic
health record (EHR) and the EHR must have a module to
record results and quality control (QC) for manual POC
testing. While most devices offer connectivity, all
connectivity is not created equally. One only needs to
look at bedside glucose testing to get a clear picture
on the number of options available.
more >
New Go-to Guide for
Solving POC Conundrums
CAP Today, January 2011,
Feature Story, by Karen Lusky
A patient with type 1 diabetes has a 450 mg/dL
fingerstick glucose value when tested at a clinic but a
100 mg result when the central lab repeats the test on
another specimen. An emergency department physician
complains that the ED point-of-care pregnancy test
results are suddenly all positive. The Clinical and
Laboratory Standards Institute’s new consensus
guideline, “Quality Management Approaches to Reducing
Errors at the Point of Care,” is aimed at helping labs
and health care providers parse and preempt those types
of problems and many more.
more >
Glycemic
Control Economics in the ICU
Scurlock C, Raikhelkar J, Mechanick JI, Curr Opin
Clin Nutr Metab Care. 2010 Dec 29. [Epub ahead of
print]
Currently the USA has an
aging population, with increasing deficits and a
healthcare system that most would agree is in
need of repair. Finding ways to curtail costs is
urgently needed. Attention to glycemic control
and metabolic care offers a cost-effective
method of treatment to reduce complications.
Healthcare-related expenses
occupy an expanding portion of gross domestic
product in the US and are a driver of the
deficit.
more >
Glucose Meters
in
the ICU
By Brad S. Karon, MD, PhD, 14
January 2011 At the
bedside: poct - advance/Laboratory
The subject of glucose meter accuracy for use in
monitoring critically ill patients on glycemic control
protocols has received an incredible amount of attention
lately. Some of the issues surrounding this controversy
are summarized here.
Prior to 2001, the “state of the art” in critical care
was to monitor glucose levels in critically ill patients
and intervene (with insulin administration) only if
glucose levels exceeded 200 mg/dL. In 2001, Van den
Berghe and colleagues published the first of their
studies on glycemic control.
more
Advances in POCT
POCT will continue to be driven by technology and the
need to produce results in a timely manner
By Adetoun
Ejilemele, MBBS, FMC Path, FWACP, and Anthony O.
Okorodudu, PhD, MBA, DABCC, FACB
ADVANCE for Administrators of the
Laboratory, Top 10 Features of 2010
The widespread use of point-of-care testing (POCT) has
become feasible thanks to improvements in the ease of
use of instruments and enhancements in automation. In
many cases, software applications have been incorporated
into the instruments to provide automated calibration
and quality control. There's also been a shift away from
the use of liquid reagents to solid-phase reagents and
electrochemical methods.
more >
POCT key to widespread
access to healthcare
By Harry
Glorikian, BA, MBA; Aruna Rajan; and Kerry Xie, Medical
Laboratory Observer, January 2011
Decentralization
of healthcare is a major trend impacting the delivery of
in vitro diagnostics and is driving the need for
point-of-care testing/tests (POCT). With fast turnaround
times (TAT) and portability to a variety of settings,
POCT offers many advantages for disease management. POCT
enables migration from core hospital labs to
specialty-care units, doctors’ offices, and homes to
provide access to healthcare services, thus improving
patient compliance, reducing hospital stays, and
lowering overall healthcare costs.
more >
CLSI
Publishes Quality Practices in Noninstrumented POCT
The Clinical and
Laboratory Standards Institute(CLSI) recently published Quality
Practices in Noninstrumented Point-of-Care Testing: An
Instructional Manual and Resources for Health Care
Workers; Approved Guideline (POCT08-A). This
instructional guideline delivers laboratory science
concepts and activities with the goal of increasing
knowledge and quality of laboratory testing for testing
personnel with little or no laboratory background. “POCT08-A is
designed to make the basic principles of good laboratory
practice accessible to all the diverse personnel
performing noninstrumented tests at the point of care.
It contains discussion and
examples of basic practices that support accurate
testing, and an extensive set of forms and protocols to
use as resources for those managing such testing,” said
Sheldon Campbell, MD, PhD, FCAP, Yale University School
of Medicine, and chairholder of the subcommittee that
created the
document.
more >
Three Cs of Coagulation Testing
Avoid interferences & find an approach to specimen
rejection that works for your lab
By Jill
Hoffman, posted December 27, 2010, ADVANCE for Medical
Laboratory Professionals
The most common coagulation tests are prothrombin (PT)
and activated partial thromboplastin time (aPTT).
Physicians will often order PT to determine the degree
of blood anticoagulation in patients using
anticoagulants or blood thinners such as Warfarin as
well as to detect acquired bleeding disorders (e.g.,
vitamin K deficiency and liver damage).
PT is more commonly reported in the International
Normalized Ratio unit system. aPTT detects hereditary
clotting abnormalities and monitors heparin therapy.
Both tests are often ordered in conjunction.
more >
More
Hospitals Advertise Shorter Patient Wait Times for
Emergency Departments
The Dark
Report, November 29 2010
New
trend pressures clinical pathology laboratories to
shorten turnaround times for key lab tests Anyone
who says there’s not much competition for patients has
ignored the marketing battle among hospitals to attract
patients to their emergency departments (EDs). In a
growing number of cities, major hospitals now
aggressively advertise guarantees of ever-shorter wait
times in their EDs. This trend has a direct impact on
clinical pathology laboratories because they must
improve turnaround time (TAT) on lab test results to
support faster patient care in EDs. Using the promise of
faster patient access to a doctor in the ED is a
fascinating phenomenon. It shows that patients do
recognize the difference in service they get from
hospitals in their community.
more >
The International
Normalized Ratio: A Tool for Monitoring Warfarin
Therapy
Warfarin is a widely
prescribed oral anticoagulant that acts by inhibiting
vitamin K-dependent coagulation factors in blood. Too
much warfarin, however, causes bleeding and can even
result in death. Therefore, dosage of the drug must be
individualized for each patient. To avoid adverse events
associated with warfarin such as excessive bleeding,
clinicians regularly monitor patients’ anticoagulation
status using prothrombin time (PT) and the international
normalized ratio (INR). Individuals who are at risk for
bleeding while receiving warfarin include the elderly,
as well as patients with liver disease, congestive heart
failure, or those on hemodialysis. Recent major surgery,
malnutrition, hyperthyroidism, and many drugs, including
amiodarone (an anti-arrhythmic), also increase the
chances of bleeding. Furthermore, there are also
important genetic factors that modulate the response to
warfarin. Patients with such risk factors may benefit
from more frequent monitoring, careful dose adjustment
to desired INR, and shorter duration of therapy.
Clinicians also commonly use PT and INR to assess
patients’ hemostastic systems.
more
Report Finds Drop in
MRSA Infections
A new report released by the American Medical
Association found that the number of invasive
healthcare-related methicillin-resistant Staphylococcus
aureus (MRSA) infections has decreased among patients
with healthcare-associated infections that were acquired
in community settings. MRSA infection rates also
declined among those with hospital-onset invasive
disease.
more
Tight Glycemic Control:What Do We Really Know,
and What Should We Expect?
Tight glycemic control has engendered large numbers
of investigations, with conflicting results. The
world has largely embraced intensive insulin as a
practice, but applies this therapy with great
variability in the manner of glucose control and
measurement. This commentary reviews what we
actually know with certainty from this vast sea of
literature, and what we can expect looking forward.
more
Exploring the Relationship between Hyperglycemia and
Surgical Site Infection
Study Suggests
Potential Glycemic Target
AACC
Clinical Laboratory Strategies, November 2010, by Genna Rollins
Numerous studies have examined the impact of tight
glycemic control in different populations of
hospitalized patients, with varying results. Some have
found benefits such as reduced surgical site infections
(SSI), while others have reported harms like increased
mortality. Now, new research examines the impact of
perioperative hyperglycemia on the incidence of SSI in
general and vascular surgery patients. NOTE:
viewing the rest of this article requires AACC
membership.
more >
Strengthening POCC Support
ADVANCE for
Administrators of the Laboratory, November 2010 At the
Bedside, by Rebecca Taalbi, point-of-care coordinator,
Wheaton Franciscan Healthcare, St. Francis Hospital,
Milwaukee, WI.
Do point-of-care (POC) employees belong to nursing or to
lab? Who should pay for the oversight? What is fair pay? These are typical
questions from managers and technicians alike.POC coordinators (POCC) are responsible for ensuring
that nursing staff perform accurate, error-free lab work
but in this role do not work with patient samples.
Because of this, some lab employees feel POCCs should be
budgeted into nursing staff. They argue that the lab
should not accrue a cost to perform oversight that
offers no revenue.
more >
Packing POC Dossier into
New Online Tool Kit
It’s often said
that to get what you want, you have to identify what
you want. And what Eileen Esposito, RN, DNP, wants
is more pathologists who are willing to collaborate
with colleagues on point-of-care testing.
“I want someone
who can sit at a table with the end users and not
say, ‘You can’t have that point-of-care test,’ but
‘Let’s talk about the test you’re requesting, and
let’s talk about its pros and cons,’” says Esposito,
assistant executive director of ambulatory patient
care services and quality, North Shore-Long Island
Jewish Health System, Manhasset, NY, and a
consultant to the College’s POC Testing Committee. more
Strengthening Care
By Steven
Melnick, PhD, MD, Advance for Administrators of the
Lab • Issue 9 • Page 16
At
The Bedside Every day, clinical
laboratories are faced with an expanding set of
challenges in providing timely patient care.
Staffing shortages, new technology and
increasing demands for accountability from the
healthcare industry mean that laboratory
directors must routinely implement new patient
testing protocols and data management
techniques. Point-of-care
testing (POCT) is an important component of
comprehensive testing in today's laboratories.
At Miami Children's Hospital, our laboratory
manages, integrates and centralizes POCT
information originating from the intensive care
units, operating rooms, emergency department
(ED), off-site centers and air and ground
transport to ensure a continuum of care.
more
POCT
& AfterGlow Highlights from the AACC Annual Meeting
Bob Kaplanis
Awarded POCC of the Year!
Congratulations to Bob Kaplanis
from Banner Health in Arizona, second from left above,
(with L-R Bill Noble and Brian Gunderson from MAS and
Kim Gregory from Mass. General Hospital) who received
the CPOCT Division’s Point of Care Coordinator of the
Year award at this year’s Annual Meeting.
To see photos,
click here. Following
the Mixer, Rebecca Paw, POC Specialist from Adventist
Health in Southern Cal, right, welcomed 200+ people to
AfterGlow 2010. For more photos from
AfterGlow,
click here,
8th Annual POCC Forum Presentations Now Available
"Records and
Regulations in the Age of the EMR" drew a large audience
during the Annual Meeting and the presentations are now
available for viewing. Click on the title of image below
for a pdf of the slides.
POCT
and the CLIA SURVEY,
Gary Yamamoto,
Centers for Medicare & Medicaid Services San Francisco
Regional Office, Preparing
for a New Era in Health Care
Integrated Electronic Health Records System,
Ginger A. Baker, MS, MT (AAB)
Accounting Practices
Build a skillful
financial justification for your point of care testing
program additions and changes.
August 16, 2010
|
By Ginger A. Baker, MS, MT(AAB)
ADVANCE for Medical Laboratory Professionals
It has been a
difficult time for most. Payer mixes have changed and
financial reserves are dwindling. There has never been a
more critical need to understand the accounting methods
of determining a test's worth and cost. Savvy point of
care coordinators(POCCs) or lab managers know point of
care tests (POCT) are not as financially friendly as
their lab performed counterparts.
More
Connectivity Pitfalls at the Point of Care
By Kim
Gregory, MT(ASCP), NCA, ClS, Associate Director, POCT,
Massachusetts General Hospital, Boston, POC CONNECTIVITY
CONCEPTS, Advance for Administrators of the Laboratory
In the infancy of point-of-care testing (POCT) the newly
deemed POCT coordinator was challenged with the task of
creating compliance from chaos using a mountain of
paper", and if they were lucky, a laptop containing a
data management system for glucose meters
fondly referred to as "SneakerNet".
Read more >
Blood Glucose Meters:
Is FDA Ready
to Tighten Up Accuracy Standards?
By Bill Malone, Clinical
Laboratory News, May 2010
After
a well attended March meeting on blood glucose meters,
FDA now has support from stakeholders to work toward a
two-track regulatory approach that would distinguish the
needs of individuals monitoring diabetes at home versus
healthcare professionals maintaining tight glycemic
control (TGC) protocols in clinical settings. More >
Lessons from the
POCT Front
By Genna
Rollins, March 2010 Clinical Laboratory News
How
Can Labs Improve Implementation, Tackle Compliance
Challenges?
For at least a decade, point-of-care testing (POCT) has
been the darling of the medical diagnostics industry,
with sustained growth in testing volume and continual
technological breakthroughs. The
trend shows no sign of abating, as drivers such as the
need for hospitals and clinics to better manage capacity
and improve care, coupled with further innovations, are
making POCT ever more attractive.
Yet hospitals and
health systems continue to experience challenges in
implementing and sustaining POCT programs, at times
leaving both laboratorians and clinicians frustrated and
wary about the process. The reasons for
less-than-satisfactory outcomes are as varied as the
programs themselves, but experts cite many factors that
can make or break a POCT application.
More >
POCT Quality
By Anthony
O. Okorodudu, PhD, MBA, DABCC, FACB, Advance for
Administrators of the Laboratory - Print
The value of POCT is
mainly dependent on reducing pre- and post-analytical
errors.
Click here
Urinalysis at the Point-of-Care
Advance
for Administrators of the Laboratory, 0310
Listen in to
pieces of an interview from the February print edition
of Advance for Administrators of the Laboratory.
Maria
Peluso-Lapsley, global commercial marketing manager,
Urinalysis, Siemens Healthcare Diagnostics, spoke with
ADVANCE for the urinalysis article featured in the
February print edition.
Click here to hear her talk about some of the
benefits of performing urinalysis at the point of care,
and learn about the CLINITEK Status family of analyzers
from Siemens.
What’s New in POC
Glucose Analyzers
By Brendan
Dabkowski, CAP Today, February 2010, Feature Story
Sometimes, turning your attention away from the rest of
the proverbial forest to care for a specific tree can
prove positive. So long as you pick the right tree. For
makers of bedside glucose testing systems, the right
tree is accuracy. And growing it can yield such benefits
as fewer errors, reduced costs, and greater patient
safety.
“The most significant trend within the marketplace has
been for hospitals to demand improved accuracy of
bedside glucose monitors as hospitals adopt protocols
for better glycemic management of patients,” says Rick
Rollins, marketing specialist, Nova Biomedical. Rollins
adds that the FDA, American Association of Clinical
Endocrinologists, and Society of Critical Care Medicine
are calling for enhanced glucose meter accuracy. And as
point-of-care glucose testing expands, says Peter Karkantis, general manager of hospital and government,
Abbott Diabetes Care, “health care institutions must
have assurance that their point-of-care glucose
monitoring system provider can deliver consistent
accuracy across thousands of glucose analyzers and
millions of test strips.” More >
Eye the Basics,
Not Baubles,for POCT
CAP Today,
January 2010, Feature Story, by Anne Ford
The major gift-giving holidays may be over, but the
hankering for new gadgets continues. Just ask
point-of-care coordinators, some of whom continue to
check their metaphorical stockings for new tests as they
plead, “I’ve been a very good coordinator this year. How
about, say, a POC molecular assay for respiratory
infection?”
But focusing on the new—new assays, new platforms, new
bells and whistles—can be detrimental to achieving
excellence in your POC program, some experts say.
“There’s a lot of tantalizing technology out there that
looks really fun but that’s not practical or not
indicated,” says Cynthia Foss Bowman, MD, medical
director of clinical laboratories and director of POC
testing at Long Island Jewish Medical Center, New York.
“From my perspective, we should be making the
bread-and-butter POC testing better. I don’t want to
inhibit technical development, but I would hate to see a
barrage of new tests come out without attending to the
issues that we’ve got right now.”
For example? Not being aware of the limitations of each
type of POC test performed in your institution.
Reinventing the wheel instead of taking advantage of
vendor resources. Letting clinicians dictate which tests
are performed at the point of care.
Read more >
Glycemic
Control in the Hospital: How Tight?
Nursing, November
2009, By Christine Kessler, RN, ANP, BC-ADM, MN
Consider the latest
evidence as you explore the controversial issue of
glycemic control in critically ill patients.
PATIENTS
WITH DIABETES are often our most challenging. Although
diabetes isn’t usually the reason that patients are
admitted to the hospital, it’s the fourth most common
co-morbidity. Half of patients with type 1 and 2 diabetes
will face surgery in their lifetime. During hospitalization, up to 12% of patients who don’t
have a history of diabetes will develop hyperglycemia,
which is defined as a fasting blood glucose over 126 mg/dL
or a random glucose over 200 mg/dL. Surprisingly, these
patients will have a nearly 18-fold increased risk of
in-hospital mortality compared with the 3-fold risk
experienced by patients known to have diabetes. Recent
studies have demonstrated that better glycemic control
can greatly reduce mortality, morbidity, and hospital
costs.
So how tight should glycemic control in hospitalized
patients be? Based on recent studies, the answer to
that question remains controversial.
More >
POC
Glucose Testing in Critically ill Patients
Editorial
article from Critical Care Medicine 2009 Vol. 37, No. 10
Visual logistics and a
glycemic variability hypothesis
In this (current) issue of Critical Care Medicine, the
paper by Dr. Meynaar et al represents a step in the
right direction. It focuses on critically ill patients,
presents a systematic approach to glucose meter
evaluation, and applies locally smoothed median absolute
difference (LS MAD) curves to evaluate bedside testing.
LS MAD
curves provide compact visual representation of
performance by means of “visual logistics”— readily
interpretable and clinically relevant graphics that
reveal accuracy simultaneously at different decision
levels, which for glucose include hypoglycemia, tight
glucose control (TGC), hyperglycemia, and critical
limits.
LS MAD curves
facilitate comprehension of performance without lengthy
explanation and also show that most glucose meter
systems do not provide consistent enough measurements
for therapeutic decisions in the extremely high or low
glucose range where Dr. Meynaar et al captured too few
paired observations to arrive at a conclusion.
More >
Perspectives on Cost and Outcomes for
POCT
Elizabeth Lee-Lewandrowski, PhD, MPH, Kent
Lewandrowski, MD,
Research Core
Laboratory, Massachusetts General Hospital,
Clin Lab
Med 29 (2009)
Rapid TAT provided by
POCT main factor ultimately responsible for
improvement in outcomes
Point-of-care testing (POCT)
is usually more expensive on a unit-cost basis than
testing performed in a central laboratory. It is
difficult to manage POCT and to maintain regulatory
compliance, especially in large institutions...
More >
Higher Standards on the
Way
for
Glucose Meters?
By
Bill Malone,
Clinical
Laboratory News, September 2009: Volume 35,
Number 9
FDA Seeking ISO Revision to Improve Performance
Requirements
The FDA will consider
tightening standards for strip-based blood glucose
meters, echoing the concerns of many in the clinical lab
field who have warned for a decade that the meters are
not reliable.
More >
POC Leader Spreads Winning Ways Far & Wide
CAP
Today, September 2009, Feature Story, by Anne Paxton
July
2009 was not a bad month for the point-of-care
testing program at Nebraska Methodist Hospital in
Omaha. First, the 430-bed hospital earned
recognition from the Hospital Compare program
sponsored by the Centers for Medicare and Medicaid
Services, which placed Methodist among the elite two
percent of institutions in the nation with the
lowest mortality for heart attack patients. Capping
that accolade, the American Association for Clinical
Chemistry tapped the hospital’s point-of-care
coordinator, Brenda Franks, MT(ASCP), for its
Point-of-Care Coordinator of the Year Award.
Franks would be the first to say there’s no magic
method for a POC testing program to arrive at such a
plane, but she has a few words of advice for other
POC testing programs. Among them: Get people to
focus on the data. Pin down specific ways to reduce
errors. Solve problems through coordinated teamwork.
And make sure that POC solutions actually address
problems you are trying to fix.
Nebraska Methodist’s point-of-care program started
out with a slight advantage over most. “When
point-of-care glucose testing first became available
20-plus years ago, the laboratory here was privately
owned, so we brought it on as a phlebotomy-based
program,” Franks says. There was a benefit to that,
because every POC glucose performed was put into the
patient medical record via the hospital information
system.
More >
Avoiding POCT Deficiencies
Advance for Administrators of the Lab,
Kelly J.
Graham, Vol. 18 • Issue 9
Errors
easily arise in point-of-care testing programs;
assess yours to maintain efficiency.
A
common downside to rapidly changing, developing
and improving technologies is a struggle to
maintain a high level of efficiency and quality
with minimal errors. Point-of-care testing (POCT)
is no exception-as more facilities adopt the
practice and new platforms and applications
become available, common deficiencies in POCT
programs may arise. But in the quality-centric
healthcare industry, methods for eliminating
problems are rarely far behind the
identification of a concern. Assess your own
POCT program for the deficiencies below and
ascertain which improvement measures might work
for your facility.
Identifying Common Issues
Peggy Mann, MS, MT(ASCP), POC and Lab/Facility
coordinator, University of Texas Medical Branch,
Clinic Administration lists a few of the most
frequently seen deficiencies as:
-
lack of
required competency documentation,
-
lack of
required quality control (QC) performance,
-
failure
to recognize out-of-range QC values,
-
improper
or lack of required instrument maintenance
and/or documentation,
-
lack of
appropriate personal protective equipment
and
-
lack of
awareness that testing sites must have
appropriate CLIA certificates for the type
of testing performed.
More >
Pieces of the POCT puzzle
POC testing: changing the way
patient care is delivered
By Kristin N. Hale, BS, BA, and Gerald J. Kost,
MD, PhD, MS, FACB, MLO,
June 2009
Point-of-care testing (POCT) is defined as
testing at or near the site of patient care. The
goal of POCT is to facilitate rapid diagnosis
and faster treatment decisions to improve
patient care and reduce morbidity and
mortality.1 POCT impacts every branch of the
healthcare system, including hospitals,
outpatients, and disaster and emergency
situations. The ability of POCT to be utilized
in all these respective locations has
demonstrated the significant potential POCT has
to positively impact and change the way
healthcare is delivered to the patient
population — ultimately, with the goal of
improving patient care — wherever that may be.
More >
Positive Patient Outcomes
The Joint Commission has implemented key changes
in 2009 that enhance focus on quality and
patient safety.
By Margaret
Peck, MS, MT (ASCP) Advance for Admin of the Lab:
May 2009
Safe, quality patient care is highly dependent
on the excellence of laboratory services, yet
laboratories quite often rely on external
processes and staff that impact its ability to
provide timely, quality results. The landmark
1999 Institute of Medicine report To Err is
Human stated that 70 percent of laboratory
errors occur in the pre- and post-analytical
phases of laboratory testing. Therefore, the
interface between the clinical laboratory and
other care providers can be a crucial part of
the entire scope of the provision of lab
services.
More >
Aiming
for Lab-like Accuracy at the
Point of Care
CAP Today, April 2009, Feature Story, By Brendan
Dabkowski
American
frontiersman and gunslinger Wyatt Earp is credited
with the gem “fast is fine, but accuracy is
everything.”
Though physicians at
the point of care are unlikely to find themselves in
an Old West-style gunfight, most, like Earp, would
choose accuracy over speed. And that means makers of
bedside glucose testing systems must be ever
vigilant in meeting customers’ requests for improved
accuracy.
“The primary need for clinicians using POC glucose
monitors is that they give accurate results—even in
the presence of interfering substances like maltose,
abnormal hematocrit, ascorbate, etc.—so that correct
treatment decisions can be made,” says Ron Newby,
Nova Biomedical’s director of marketing. Also
crucial: obtaining the right glucose read the first
time, at the point of care, to eliminate the
“time-wasting need for repeat measurements,” he
says. Analyzers must deliver results quickly, but
without sacrificing accuracy. Hospitals now face the
“need to provide even higher levels of accuracy in
handheld devices, in effect delivering lab-like
accuracy at the bedside,” says Mary Catherine Coyle,
MS, MT(ASCP), director of product marketing in the
professional diagnostics division of Roche
Diagnostics.
More >
Win-Win POCT
Scott
Warner, MLT(ASCP),
ADVANCE
for Administrators of the Laboratory
Vol. 18 • Issue 3 • Page 10 At
the Bedside
Imagine 10
employees in your small hospital laboratory.
Suddenly, there are 30 more performing tests on all
shifts, and as a manager you aren't sure if they are
fully trained or understand quality control (QC)
concepts. This can happen with point-of-care testing
(POCT).
With diabetes being the sixth
leading cause of death1and accounting for 22 percent
of hospital charges,2your hospital's POCT program is
a crucial part of managing inpatient diabetic care.
Your partnership with nursing is the key to success,
whether starting from scratch or upgrading an
existing program.
More
BNP in the Diagnosis of
Heart Failure
By Barry I. Bluestein, PhD,
MT(ASCP); Normand Despres, PhD; Alexander Belenky,
PhD; Farooq Ghani, MD, PhD; and E. Glenn Armstrong,
PhD,
ADVANCE
for Administrators of the Laboratory
Heart failure or congestive heart failure (CHF),
when heart failure patients experience a buildup of
fluid, is a clinical syndrome characterized by
shortness of breath, fatigue and peripheral edema
caused by the heart's inability to adequately
circulate blood to the body's essential organs. CHF
has become so common that it is considered by some
to be a new epidemic.1 This dysfunction is
associated with coronary artery disease (CAD),
chronic hypertension, valvular heart diseases and
cardiomyopathies.
The World Health
Organization now estimates that 16 million people
worldwide are living with some degree of heart
failure. Approximately two-thirds of those,
according to the National Institutes of Health, will
die within five years of their diagnosis. Eighty
percent of hospitalized patients age 65 and older
are admitted with a diagnosis of CHF, making it the
most common diagnosis of hospitalized patients in
that age group.2 As a result, more Medicare dollars
are spent on heart failure than any other single
diagnosis.
More
POCT Precision
Accuracy of
point-of-care testing devices is proven; educating
testing personnel is key.
By
David Plaut and Carol Smola, Advance for the
Administrators of the Lab
Advance for
Administrators of the Lab February 2009 issue has a
great article on POCT and reports that the demand
for POCT is expected to increase by 80 percent over
the next three years. The article states that
the market is forecasted to grow from $10.3 billion
(2005) to $18.7 billion by 2011.
Click here to visit Advance for
Administrators of the Laboratory website and then
under CURRENT ISSUE, click on the "Log in to View
Digital" button. That will take you to a really cool
digital version of the publication.
Point-of-Care Sagas:
A
Tale of Three Cities
CAP
Today, January 2009, Feature Story, by Anne Paxton
Baystate Health in Springfield, MA; Mayo Clinic
in Rochester, MN: and SUNY Downstate Medical Center
in Brooklyn, NY talk about their POC programs...
As increasingly
complex laboratory tests start being performed
rapidly at the bedside and elsewhere, the steady
migration of testing from central laboratory to the
point of care seems inexorable. But laboratory
managers and directors in many care settings can
confirm that, when point-of-care testing is adopted
too hastily, it can be a case of the technology tail
wagging the diagnostic testing dog.
At
Baystate Health in Springfield, Mass., for example, “We do a
complex menu of point-of-care testing, and we’re
dealing with dozens of sites, hundreds of devices,
and thousands of operators,” says James H. Nichols,
PhD, DABCC, FACB, director of clinical chemistry.
Sometimes, “physicians say ‘I need POC testing,’ and
think it’s going to solve all the problems of the
world—when in fact it can just throw another wrench
of technology into an already overburdened system.”
Read more >
New
Glycohemoglobin Standard:
Will Estimated Average Glucose Boost Patient Understanding?
By John R. Bell,
Clinical Laboratory News, October 2008:
Volume 34, Number 10
Despite the widespread use of HbA1c as a
clinical measurement of patients’ diabetes control, standardization
of test results has been a challenge for labs. The National Glycohemoglobin Standardization Program took the first step 12 years
ago when it initiated a program to standardize HbA1c measurements on
the basis of the Diabetes Control and Complications Trial, results
of which were published in 1993.
Read more >
Consensus from Endocrinologists on Prediabetes Testing
Lab Tests Online,
October 2008
New guidelines from two major endocrinology organizations recommend
strategies for diagnosis and management of prediabetes, a condition
that occurs when blood glucose levels are higher than normal but not
elevated enough to warrant a diagnosis of type 2 diabetes.
The guidelines are an extension of efforts to detect and treat type
2 diabetes earlier and more aggressively, according to AACE. They
aim to help physicians recognize prediabetes, those at risk for
developing full-blown diabetes, and to make treatment decisions to
prevent diabetes and ameliorate many of its risk factors. These
include unhealthy weight, high blood pressure, and elevated lipid
levels.
Read more >
Putting Hospital
Data
to Hospital-wide Use
,
Anne
Paxton
Implementing a tight glycemic control protocol in the hospital
should be straightforward: Monitor blood glucose levels, assess
how well they’re meeting target ranges, use the information to
improve, and reap the benefits in shorter lengths of stay and
lower mortality and costs.
But even when hospital staff are
eager to comply with the protocol, the challenge of getting the
right data together can hamper hospitals’ ability to benefit
from tight glycemic control, or TGC.
More >
POCT in the ED Enables Quicker Treatment
Clinical Lab Products
Patient side
point-of-care testing -- where diagnostic testing is conducted
at or near the site of the patient -- enables doctors to make
decisions on patients presenting with chest pain up to 20
minutes faster than those whose lab tests are evaluated by a
standard lab, according to a study appearing this
month in the peer-reviewed journal Annals of Emergency Medicine.
More >
Platform Consolidation in Critical Care
Advance for the
Administrators of the Lab
POC Connectivity, October 2008 By Brad Karon, MD, PhD
Recent consolidation of testing platforms has been driven by two
factors—increasing evidence for improved patient care outcomes for
analytes such as glucose, lactate and creatinine and the desire to
use a single platform in multiple patient care settings.
Read more >
Stuck in the Middle
of Middleware
By Deborah Levenson, May
2008, Clinical Laboratory News
Labs
Look for Answers as New Consortium Aims to Untangle
the Mess
Mention
“middleware” in a room full of lab directors, and
you are likely to hear varied definitions of what it
is and a wide array of uses for it. But generally
speaking, the term has come to describe any hardware
and software that acts as an intermediary between
instruments and lab information systems (LIS) and
allows them to exchange data or perform data
management tasks the LIS can’t.
Middleware’s popularity took off in the early 1990s
when personal computers that generated reports and
buffered results became more common. Since then,
middleware has become mainstream in POCT and a
common, relatively inexpensive solution for core
labs grappling with a wide range of problems
including shortages of med techs, increases in test
volume, more complex devices and lab operations, a
federal push for electronic health records, and an
overall trend toward ensuring quality of care.
Connectivity Success
Two major data
management systems for POCT now comply with the
CLSI’s connectivity standard, easing the transfer of
data in institutions with labs that use these
systems from Telcor (Lincoln, Neb.) and Medical
Automation Systems (Charlottesville, Va.).
Connectivity enabled by the standard and compliant
systems not only improves patient care, but also
eases billing and compliance documentation.
With the
forthcoming IICC standard, core labs may one day
enjoy the sort of connectivity POC users and lab
staff at Carolinas Medical Center-NorthEast in
Concord, N.C. now have. With the aid of
her RALS+ system from Medical Automation Systems and
its ability to connect to Roche Accuchek Inform
glucose meters, Laboratory Education and POC
Coordinator Deb Norkett, MT, ASCP has seen marked
improvements in compliance and billing. She
interfaces all manual tests through the Accucheck,
which also allows her to enter pregnancy test
results. After taking advantage of that function,
she now achieves a 100% billing rate, while in the
past she grappled with a 15% deficit in billing
because of lack of documentation in the emergency
room.
“Before using
RALS, we couldn’t capture figures on the volume of
certain manual tests, so they were built into the
room charge,” she recalled.
Click here for more >
Never Give In - Fighting for POC
Patient Safety
Cap Today,
By Anne Ford
In
grammar school, the “three Rs” still hold sway (or
so we all hope). But in point-of-care testing,
there’s just one R that matters: Relentless. It’s a
word that comes up over and over again in
conversation with hospital POC testing
coordinators—yes, even more often than “specimen” or
“CLIA.”
“People pretty much
know I’m relentless about certain things,” says Tim
Deen, MLT(ASCP), MT (HEW), POC testing manager at
Medical City Hospital, Dallas. “My chief nursing
officer has kindly referred to me as a ‘tough-love’
type of person.”
More >
In that regard he has a lot in
common with Deb Phaup, BS (MT), MT(ASCP), CLS (NCA, POC coordinator at Mount Auburn Hospital, Cambridge,
Mass. “I’m relentless,” she admits, laughing.
POC testing safety
is
nothing to joke about
Personable as Deen
and Phaup are, they know that POC testing safety is
nothing to joke about. With thousands of POC tests
performed in their hospitals each month, theirs is
not exactly a sit-back-and-relax situation. With
their colleague Joann Bauwens, BS(MT), MT(ASCP),
MA(HSM), interim director of laboratory services and
POC testing coordinator at SSM St. Mary’s Health
Center, St. Louis, Mo., they provide insight into
what keeps POC testing on the safe side.
Both Deen and Phaup
assumed their POC responsibilities just over a
decade ago, when bedside testing wasn’t as
frequently conducted or as closely regulated as it
is now. When Deen began, he says, Medical City
Hospital’s point-of-care program was “a lax system,
where the lab was not involved.” And at Mount Auburn
Hospital, where the POC coordinator position was
created for Phaup, “nobody even knew what POC
testing was,” she says. “The first week I started
the job, I came into work and the then-manager
didn’t even know where to put me. I was just
standing in the hall without a clue.”
Click here for more>
Putting
POCT in good hands
CAP Today,
Waived
testing? Wave goodbye to that, says William A.
Rock Jr., MD, medical director of the clinical
laboratory, University Hospitals and Clinics,
University of Mississippi Medical Center, Jackson,
who did just that when he began putting together a
point-of-care testing program for his institution a
decade ago. Today, he and three other colleagues run
an extensive POCT program that involves 61 sites and
more than 2,000 employees at three hospitals and a
large outpatient clinic—all without relying on the
waived tests that typically anchor POCT programs.
Waived tests are
somewhat oddball actors in the highly ordered,
detail-driven world of laboratory medicine. Though
regulated, these tests fall short on full
commitment, like the Sondheim character in “Company”
who sings, “Marry me a little.” So simple are these
tests, the FDA has cleared them for home use, and
CLIA requires test users to follow only
manufacturers’ instructions. No proficiency testing,
no patient test management, no quality assurance, no
quality control, and no personnel qualifications.
For Dr. Rock and his colleagues, it was also a
no-go. At UMMC, they decided, the POCT program would
be built to last. Any test supported in the POC
program, even if CLIA has given it waived status,
would have to meet CAP and Joint Commission
guidelines.
Click here for more.
Bedside Tests Can Speed Results,
Ease Crowded ERs
The Tennessean. 07/15/08
It used to take emergency physicians at Middle Tennessee Medical Center
an hour and a half to get back results from a blood test. That changed
to only a few minutes three months ago when the hospital bought
equipment that allows tests to be done at a patient's bedside.
The Murfreesboro hospital is one of several in the Nashville area moving
to point-of-care testing, which a Vanderbilt professor's research calls
part of the solution to relieve emergency room overcrowding.
At many hospitals, tests are sent to labs in another part of the
building and certain results might take as long as an hour and a half to
get back to the physician. That can sometimes delay initial treatment
and push back other tests, such as X-rays that won't be scheduled until
those initial results are returned. That, in turn, may keep beds
occupied that otherwise could go to other patients. Soon, Middle
Tennessee Medical Center plans to add pregnancy and urine tests to those
performed at the bedside, a development made possible by the
availability of smaller, less costly testing units and improved
technology.
"It's been one of the biggest accelerators of our patient flow," said
Dr. Kevin H. Beier, an emergency physician who also practices at Baptist
Hospital here and is chairman of governmental affairs for the American
Academy of Emergency Medicine.
Vanderbilt, meanwhile, is considering putting a small lab within its
adult emergency department or buying some of the small portable testing
devices already on the market.
Overcrowding on
rise
The move follows a study by Dr. Alan Storrow, associate professor of
emergency medicine, that suggested putting labs or machines that
determine results closer to a patient's bedside can help solve
overcrowding in emergency rooms and perhaps free up bed space in the
main hospital more quickly. "We could see a great deal more patients in
less time because we're able to get our labs back in a much more
time-efficient manner," Storrow said.
Overcrowding has become
more of an issue as hospitals begin to see sicker patients, some of
whom don't seek care until their medical problem gets worse because
of a lack of insurance.
Every other day, at least one Nashville-area hospital sends patients
elsewhere because of a lack of room in departments such as the ER and
the critical care unit. Although Vanderbilt — where the adult and
pediatric emergency departments combined see 100,000 patients a year —
recently doubled its ER capacity to 46 beds, overcrowding still occurs.
One barrier to adopting point-of-care testing is that it often costs
less to process batches of tests in a larger main hospital or central
lab, Storrow said. "There has to be a balance between cost and
improvements in efficiency.
Speeding Toward Real
Time with POC Glucoses
CAP Today, March 2008, Feature
Article
In the case of
wireless setups for point-of-care glucose testing,
do results arrive in the electronic medical record
in real time or "real time"? And how important is
that distinction?
To
back up a moment: As reported in the
October 2007
issue of CAP TODAY ("Wireless Glucose Results-The
Latest in Real-Time Data"), the University of North
Carolina Hospitals, Chapel Hill, has implemented LifeScan's OneTouch DataLink system to greatly
shorten the length of time it takes to obtain, view,
and track point-of-care blood glucose results on
clinical workstations, laboratory IT systems, and
even physicians' PDAs. Other institutions are
gradually following suit.
The LifeScan system
speeds glucose result delivery by using a wireless
unit to transmit data from LifeScan's OneTouch
Flexx meter into the electronic medical record
rather than requiring point-of-care staff to take
the meter to a docking station for upload. Here's
what some consider the sticking point: The wireless
unit is external, meaning the user must connect it
to the meter with a serial cable before connectivity
can be established.
True, the LifeScan wireless unit
is stored in the same carrying tote that holds the
meter. But it's still an external solution."It's not real-time
wireless," says James H. Nichols, PhD, DABCC, FACB,
who, as a member of the Connectivity Industry
Consortium, helped create the POCT1-A connectivity
standard for point-of-care devices in 2001.
Dr.
Nichols is medical director of chemistry at Baystate
Health, Springfield, Mass., and associate professor
of pathology at Tufts University School of Medicine,
Boston. "It's a stepping stone on the way to real
time, but it's not there yet. It's not like you have
the device in your hand, you push the button to scan
the patient, and it communicates wirelessly with
your server. It still has that limitation of
intermittent transmitting."
Click here for more >
Integrating POCT In the ED
POC Connectivity Concepts,
Advance for the Administrators of the Lab, Vol. 17 •Issue 2
• Page 9
By
Valerie L. Ng, PhD, MD; R. Clayton Hooper, RN; Ruth
Pfeiffer, RN; Mary N. Clancy, MS, CLS; and Eberhard Fiebig,
MD
You can't get much more
diametrically opposed cultures than that of the ED and the
laboratory. The laboratory culture is one of careful and
methodical processes and quality systems designed to ensure
high-quality results and meet regulatory requirements. The
ED culture is one of speed, algorithmic medical practice and
rapid reflexive actions necessary to save lives in
emergencies; regulatory compliance tasks are often an
afterthought.
Ironically, many ED
interventions rely on accurate laboratory test results.
Point-of-care testing (POCT) results in the ED must, by
definition, be of the highest quality and always correct
because clinical action will be taken immediately based on
the test result.
Why has POCT become so important
for the ED? The backdrop is the unraveling of the healthcare
system, driving many uninsured and sick patients without
primary care access to the ED for routine or urgent (but not
emergency) medical care.
Click here for more >
Nurses on
Point-of-Care IT Usage: Study
By: Jean DerGurahian/ HITS
staff writer; Modern Healthcare Online Posted: January 4,
2008 - 5:59 am EDT
An
increase on patient safety issues, higher healthcare costs
and labor shortages are driving hospitals to use more
information technology at the point of care; however, some
devices and technology are more cumbersome than helpful,
according to a new study of nurses and their bedside
treatment practices.
The Point
of Care Computing for Nursing study, conducted by Spyglass
Consulting Group, shows that healthcare facilities are
making "significant investments" in clinical information
systems so that nurses and other practitioners can access
patient information near or at the point of care.
Nurses are
using fixed or mobile devices to search different
applications that help them treat their patients, according
to the report,
Spyglass spent four months interviewing more than 100 nurses
across the healthcare fields for its study.
It found
that 86% of acute-care nurses and 94% of home health nurses
interviewed are using devices to access reference
materials—including drug databases, manuals and medical
calculators—and make informed patient decisions.
While
nurses spend nearly half their time documenting their
treatments, 78% of nurses record their care at the patient's
bedside through IT applications, in efforts to cut down on
first writing the information on paper and then transferring
it to electronic reports, according to the study.
Another timesaver has been the use of automated products to
capture vital signs data for high-acuity patients, immediately
present it for nursing review and automatically upload it to the
patient’s electronic record, with 36% of nurses adopting this
practice. Bar coding
also has helped nurses reduce medical errors. More than half the
nurses interviewed—53%—said that they use devices to ensure
positive patient identification, medication administration,
blood transfusion verification and laboratory specimen
collection, according to the report.
Nurses are
spending time on the Internet as well to stay up-to-date on
nursing trends and new treatments, according to the report.
"Nurses discovering online nursing communities and resources
enabling them to communicate and collaborate with colleagues
more effectively," Spyglass said in its report. While nurses
seem ready to embrace point-of-care technology, they also say
devices currently available are cumbersome and difficult to move
with, and networks are unreliable, according to the report.
"Point-of-care
solutions need to evolve to provide higher levels of
synchronization and integration of hardware, software and
infrastructure to streamline nursing workflow process and
improve communications amongst care team members," Spyglass
said.
Content for
Point of Care Computing for Nursing was derived from more than
100 interviews with nurses working in acute-care and ambulatory
environments nationwide. Spyglass conducted the telephone
interviews over a four-month period beginning April 2007.
Wireless glucose
results - latest on real-time data
More than a
decade after tight glycemic control made its debut in the
early 1990s, numerous studies, and recommendations from
organizations such as the American Association of Clinical
Endocrinologists and the American Diabetes Association, have
affirmed its ability to decrease everything from mortality
and comorbidity to the risk of heart failure and organ
damage. But from a point-of-care testing coordinator's point
of view, tight glycemic control increases a few
things, too.
A few? Make
that 1,000—the approximate number of glucose results that
point-of-care staff at University of North Carolina
Hospitals, Chapel Hill, manage every day. After UNC
implemented a TGC protocol a few years ago, "the first thing
that I noticed as a point-of-care person was that it
required more glucose meters and testing strips, and more
data was being generated," says Beverly Robertson, MPH, MT (ASCP),
until recently UNC's point-of-care testing coordinator and
now a technical service representative for Somerset,
NJ-based in Ventiv Health and an authorized installer of
LifeScan equipment. In addition to reviewing and charting a
greatly increased number of glucose results, the new TGC
protocol meant that Robertson was faced with managing more
frequent data downloads and data flow bottlenecks. Not only
were there more results to deal with, but "all those results
were being hand-charted," Robertson says. "And the only way
that physicians could review them was to be physically at
the nursing locations." In a large institution like UNC,
which has 750 beds, 100 units, and nine ICUs, that meant
relying on what Connie Bishop, MT (ASCP) SH, UNC assistant
administrative director of core laboratories and
point-of-care testing, laughingly terms the "sneaker
network."
Click here for more>
The
Challenges of Point-of-Care Connectivity
How A New Tool Can Aid Labs
with Device and Data System Purchasing
By Deborah Levenson,
Clinical Laboratory News, July 2007
Point-of-care testing (POCT)
devices with the ability to link to each other and lab
information systems (LISs)—known as connectivity—can help
reduce medical errors, improve staff compliance with
regulatory requirements, boost revenue from testing, and
track wasted supplies.
In most labs,
POCT connectivity has come a long way from the 1990s, when many
POCT devices lacked essentials such as ports that allowed them
to transfer results to a lab data management system or ports
with keypads for data entry. In those early days, a few
manufacturers offered instruments that allowed labs to move data
from the device to a patient’s chart, but each had its own suite
of products, necessitating multiple computers to handle data.
Today, while issues with POCT connectivity are not as
troublesome, labs often fall short of the ultimate goal of using
such devices: fast, complete transfer of accurate information.
Click here for more >
Utilization of a Computerized Intravenous Insulin Infusion
Program to Control Blood Glucose in the Intensive Care Unit
Rattan Juneja, Corbin Roudebush,
Nilay Kumar, Angela Macy, Adam
Golas,
Donna Wall, Cheryl Wolverton, Deborah
Nelson, Joni Carroll, Samuel J. Flanders.
Diabetes Technology &
Therapeutics.
Jun 2007, Vol. 9,
No. 3:
232-240
This proof of concept study was designed
to evaluate the safety and effectiveness of an intravenous
insulin dosing calculator, the Clarian GlucoStabilizer™
program, and to determine the feasibility of its use as part
of a glycemic control program. This paper discusses the
impact of the GlucoStabilizer program on the glycemic
control of intensive care patients with hyperglycemia.
Patients admitted to the intensive care unit
(ICU), requiring intravenous insulin, were treated using the
GlucoStabilizer program. This program calculates an insulin
drip rate based on the low and high blood glucose (BG)
levels of the desired target range, the patient's current
and previous BG levels, and an insulin sensitivity factor,
with a goal of safely and expeditiously achieving and
maintaining the patient's BG in the target range.
From October 2004 through March 2006, the
GlucoStabilizer program has been used to treat 2,398
patients in the ICUs, with 177,279 BG measurements in its
database.
For
more on this study, or to request a copy,
click here.
Intensive Insulin Protocol
Improves Glucose Control and Is Associated with a Reduction in
Intensive Care Unit Mortality
Charles C Reed, BSN, Ronald M Stewart, MD, FACS, Michele
Sherman, BSN, John G Myers, MD, FACS, Michael G Corneille, MD,
FACS, Nanette Larson, BSN, Susan Gerhardt, MSN, Randall Beadle,
BSN, Conrado Gamboa, MS, RPh, Daniel Dent, MD, FACS, Stephen M
Cohn, MD, FACS, Basil A Pruitt Jr, MD, FACS. American College of
Surgeons, 2007
Intensive insulin therapy to maintain serum glucose levels
between 80 and 110 mg/dL has previously been shown to reduce
mortality in the critically ill; recent data, however, have
called this benefit into question.
In addition, maintaining
uniform, tight glucose control is challenging and resource
demanding. We hypothesized that, by use of a protocol, tight
glucose control could be achieved in the surgical trauma
intensive care unit (STICU), and that improved glucose control
would be beneficial. During the study period, a progressively
more rigorous approach to glucose control was used, culminating
in an implemented protocol in 2005.
We reviewed STICU patients’ blood glucose
levels, measured by point-of-care testing, from 2003 to
2006.Mortality was tracked over the course of the study, and
patient charts were retrospectively reviewed to measure illness
and injury severity.
For
the results of this study,
click here to access the pdf file.
Glucose Test
Frequency Spawns
New Analyzer Needs
Anne
Ford
In dieting—as in so much else—good
intentions aren’t enough. To lose weight, calorie-counters can’t
stock up on carrot sticks and hope for the best; they have to
actually monitor their diet via a food diary or some other
method. (Hence the saying: “If you bite it, write it.”) But if
the monitoring method becomes too cumbersome, it’s likely to go
by the wayside, and any new, healthier eating habits will
probably follow.
Conversely, making the monitoring
process as painless as possible is a major step toward success.
And that’s a lesson that applies to many endeavors, including
tight glycemic control.
“Because
of the increased testing frequency mandated by most tight
glycemic control protocols,” says LifeScan marketing manager
Grant Choe, “anything we can do to increase ease and simplicity
is going to be welcomed with open arms.” Harlan Polishook, Nova
Biomedical marketing communications manager, agrees: Under tight
glycemic control protocols, he says, some nurses find themselves
performing bedside glucose testing “as frequently as every half
hour for some patients.” In turn, “more frequent bedside testing
has driven the demand for faster, easier testing and smaller
blood volumes.”
The
makers of the
bedside glucose testing systems featured in this month’s
instrumentation survey have responded to that demand
with new and forthcoming instruments and features, from multiple
measuring wells to wireless capabilities.
Click here for more >
Industry Overview
Surprise, We’re Here!
Gearing up for
unannounced inspections
By
Renee DiIulio
In 2004, deficiencies at Maryland
General Hospital (MGH) in Baltimore brought oversight attention
to the process of laboratory accreditation and inspections. The
title of a resulting Government Accountability Office (GAO)
report, published in June 2006, summarizes the result: “Clinical
Labs: CMS and Survey Organization Oversight Is Not Sufficient to
Ensure Lab Quality.” Something had to change. Congressmen called
for a switch to unannounced inspections. At the same time, the
Joint Commission on Accreditation of Healthcare Organizations
(JCAHO), Oakbrook Terrace, Ill, was in the process of altering
its accreditation process, implementing a plan named Shared
Visions—New Pathways, which became effective January 1, 2004.
“In 2004, JCAHO announced its intent
to implement unannounced surveys in 2006 as part of our Shared
Vision—New Pathways effort,” says Margaret Peck, MS, MT(ASCP),
the organization’s director of the lab accreditation program.
The goal was to provide a more accurate picture of a
laboratory’s day-to-day function. “It would allow our
accreditation process to be used as a systems improvement tool,”
Peck says.
College of American Pathologists
(CAP) followed suit, influenced, says R. Bruce (RB) Williams,
MD, pathologist and head of CAP’s accreditation committee, by
the concern of the GAO and Congress. “We are continually
improving our lab accreditation process, and we underwent a
systemic review following MGH,” he says. A subsequent bill—HR
686: Clinical Laboratory Compliance Improvement Act of 2005,
introduced by Rep Elijah Cummings (D-Md)—aims to make
unannounced inspections a requirement if passed.
Click here for more >
When
POC Connects the Data, Everyone Wins
The
story of point-of-care connectivity is quickly becoming one of
laboratory medicine’s twice-told tales: POC setups have come a
long way, and hospitals are reaping the benefits. For Debra
Norkett, MT (ASCP), education coordinator for the laboratory and
point-of-care coordinator at NorthEast Medical Center, a 457-bed
hospital in Concord, NC, incorporating POC test data into an
electronic patient record system is the ultimate goal. “Our
hospital is working toward having electronic patient records,
and theoretically, point-of-care connectivity has been set up to
support such a system,” she says.
NorthEast Medical Center
implemented POC connectivity about three years ago, beginning
with the installation of a positive patient identification
system that uses bar-coded patient wristbands in conjunction
with bar-coded POC instrument operator badges to capture the
data from each encounter that involves a POC test. “The success
of our POC connectivity is tied into our bar-code system. The
bar-coded wristbands and badges have enabled us to reduce
patient misidentification errors, as well as automate POC test
ordering and result reporting,” Norkett says. Since bar coding
became part of the POC process at NorthEast, patient
identification errors have dropped to below one percent.
Because NorthEast installed its
vendor-neutral Rals-Plus POC data-management system at the same
time it implemented its positive patient identification system,
POC connectivity has always been enabled by the bar-code system.
“I took the job of POC coordinator a few years before we
implemented POC connectivity. Then, we had about 30 glucose
meters and I would carry a laptop from unit to unit and actually
download the information,” Norkett recalls. “At the time, it
took so long to gather the data that report generation was
always about a month after the fact.”
Click here for more >
CAP Today, March 2006, Cover
Story
Nearing High Tide on Low Blood Sugars
By Anne Paxton
Since its emergence in the early 1990s, tight
glycemic control could almost have been called an orphan
protocol. Despite evidence that it sharply lowers patient
mortality and morbidity and hospital length of stay, the use of
insulin to keep patient's blood glucose at or near normal levels
has spread slowly beyond a few pockets of fervent support, and
has yet to sweep the nation's hospitals. As Curtiss B. Cook, MD,
associate professor of medicine in the Division of Endocrinology
at Mayo Clinic Arizona puts it: "A lot of people haven't quite
bought into the concept yet."
But in recent weeks, with a major new
controlled study and a public statement from leading
professional associations in diabetes care, tight glycemic
control may have reached its tipping point. The American
Association of Clinical Endocrinologists and the American
Diabetes Association are now advocating widespread adoption of
tight glycemic control protocols not only in intensive care
units but also in other areas of the hospital. Their position
statement, released Feb. 1, calls for implementing "structured
protocols for aggressive control of blood glucose in both
intensive care units and other hospital settings."
One day later, Belgian researchers led by
Greet Van den Berghe, MD, PhD, reported in the
New England Journal of Medicine (354:449-461)
that intensive insulin therapy, or tight glycemic control,
significantly reduced morbidity among all patients in the
medical ICU—a benefit that was demonstrated earlier on patients
in surgical ICUs.
Click here for more >
Avoiding
Glucose Monitoring Errors in Patients Receiving Other Sugars
FDA issued a reminder about the potential for falsely elevated
glucose readings in patients who are also receiving products
that contain other sugars. These products include oral xylose,
parenterals that contain maltose or galactose, and peritoneal
dialysis solutions that contain icodextrin.
A patient recently died because of this problem. His glucose
readings were very high, so he was given aggressive insulin
treatment. The glucose readings were falsely high, however, and
too much insulin was administered. The patient suffered
irreversible brain damage and died. In this case the glucose
meter was reading the patient's actual blood glucose level, plus
the maltose that was contained in the IV immune globulin he was
receiving. The readings were falsely elevated because the
glucose monitoring device couldn't distinguish between glucose
and other sugars. All glucose meters don't suffer from this
problem. There are four kinds of enzymatic glucose monitoring
methods that are used, and only one of those has this problem.
This problem occurs only with the monitoring method that uses an
enzyme called GDH-PQQ. This method is employed in some glucose
monitoring devices used by diabetics at home and in
point-of-care settings.
The other three test methods currently used in glucose
monitoring systems are called GDH-NAD, glucose oxidase, and
glucose hexokinase, and they are capable of distinguishing
between glucose and other sugars. The test method used in
glucose meters is identified in the package insert that comes
with the glucose test strips. The package insert is also
available from the manufacturer. The most important thing to
remember is not to use the GDH-PQQ method if the patient
recently received other sugars. That includes oral xylose for a
D-Xylose absorption test, or an IV solution containing maltose
or galactose, or a peritoneal dialysis solution containing
icodextrin.
Click here for more >
Additional
Information:
FDA MedWatch Safety Alert 2005 - Parenteral Maltose/Parenteral
Galactose/Oral Xylose-Containing Products:
Major
Medical Associations Call for Better Blood Glucose Management in
Hospitalized Patients
WASHINGTON, DC – February 1, 2006 –
The American Association of Clinical Endocrinologists (AACE),
American College of Endocrinology (ACE – the scientific and
educational arm of AACE) and the American Diabetes Association
(ADA) have joined forces to develop strategies for management of
adult patients with high blood glucose (sugar) in hospitals.
Co-sponsored by ten other major medical associations, AACE and
ADA released a new position statement today on improving
inpatient glycemic control at a joint consensus conference.
Awareness about the
importance of glycemic control in the hospital setting has
increased as result of the ACE Consensus Development Conference
on Inpatient Diabetes and Metabolic Control in 2003. In order
to suggest a plan for better care, AACE and ADA came together to
conduct the “Improving Inpatient Diabetes Care: A Call to Action
Conference - Consensus Development Conference,” January 30 and
31, 2006 in Washington, DC.
Click here for more >
Tight Glucose Control Cuts
Heart Disease by Half in
Type 1 Diabetes
Published by the U.S. Dept. of Health and Human Services - NIH
News
Intensive
glucose control lowers the risk of heart disease and stroke by
about 50 percent in people with type 1 diabetes, researchers
report in the
December 22, 2005, issue of the New England
Journal of Medicine. Their findings are based on a
follow-up study of patients who took part more than a decade ago
in the Diabetes Control and Complications Trial (DCCT)
www.diabetes.niddk.nih.gov/dm/pubs/control/index.htm,
a major clinical study funded by the National Institutes of
Health (NIH).
“We see a greater reduction in
cardiovascular events from intensive blood glucose control than
from drugs that lower blood pressure and cholesterol,” said Saul
Genuth, M.D, of Case Western University. Genuth chairs the
follow-up study of DCCT participants, called the Epidemiology of
Diabetes Interventions and Complications (EDIC) study, which is
examining the long-term effects of prior intensive versus
conventional blood glucose control.
“The benefits of intensive
control strongly reinforce the message that this therapy should
begin as early as possible and be maintained as long as
possible.”
Click here for more >
Opening up the throttle on
POC-hospital connectivity
CAP
Today, December 2005, Feature Story
By Anne Paxton
For point-of-care testing managers,
true connectivity is now within reach, which means tantalizing
efficiencies lie ahead. POC departments are aligning their
connectivity solutions with hospital wide moves to sharpen
treatment protocols and become paperless and wireless. For many
POC testing programs, the integration of it all is complicated by
the demand for bedside testing—and its brisk growth.
Six hospitals, three outpatient
clinics, and seven nursing homes make up Sentara Healthcare in the
Hampton Roads area of Virginia. Employing 300 glucose meters and
about 170 i-Stats, the Sentara system now does well over 1 million
POC tests a year, says Lou Ann Wyer, MT(ASCP), POC testing
clinical specialist with Sentara Laboratories. Like many other
health systems, Sentara has seen a sharp increase in glucose
testing because all units are using tight glycemic protocols.
Wyer's chief project now is rolling
out troponin testing in the emergency department. "For this test
there was a lot of up-front work to be done. It's been a long
process, including extensive evaluation of the cartridge—an i-Stat
product—and making sure physicians are comfortable with the method
and how to interpret results, because they don't match the main
laboratory results. They have different cutoff values."
Click here for more >
Connective issue: Linking POC
with Wireless Hospitals
CAP
Today, November 2005, Feature Story
By Anne Paxton
Most point-of-care
testing managers are thrilled with the new devices and software
available to streamline their operations. But with connectivity
becoming standard operating procedure, POC testing programs are
facing a new challenge: making sure that connectivity meshes
with hospitalwide initiatives to adopt new treatment paradigms,
eliminate patient ID errors, and eventually say goodbye to
cables and wires, as well as to paper. Whether their programs
are in a state of steady expansion or extreme makeover, POC
testing managers say the possible efficiencies now in view or
just around the corner are tantalizing.
How are they
turning the visionary schemes into smooth-functioning routines?
At Lewis-Gale
Medical Center, Salem, Va., connectivity is fairly well
established. “We have three different connectivity
solutions,” says point of care coordinator John La Rosa, MA,
CLS (NCA). “Biosite Census connectivity for cardiac
markers has been in place since 2001, we’ve had the Roche
Diagnostics glucose meters on RALS-Plus since 2002, and
Abbott Central Data Station for the i-Stats just started
this summer.”
The laboratory
and hospital information systems are from Meditech. The
software updates are included in the hospital’s three- to
five-year contracts with the vendors, and may be carried out
remotely if the vendors have access to the hospital’s
network.
“The big plus of connectivity is it allows us to capture
billing that wasn’t captured before, and make sure we are
billing to the correct account or patient. We are billing
and getting reimbursed wherever we can,” La Rosa says.
Tight glycemic
control is the hot topic of 2005 in his region, he says,
because the evidence shows that keeping patient blood sugar
under a certain benchmark prevents some infections, raises
postoperative wound healing rates, and reduces length of
stay.
“This year we kicked up tight glycemic control where we
monitor blood sugars every hour on patients on insulin drip.
Right now we just have TGC in critical areas, but when we
move it out to the whole hospital, we expect glucose testing
to go up quite a bit.”
Click here for more >
Outpatient Setting:
Alternatives to Connectivity
Vol. 14 •Issue 11 • Page 10 November 2005 Advance for
Administrators of the Lab - AT THE BEDSIDE
By
Peggy Mann, MS, MT(ASCP)
Maintaining
a unified point-of-care (POC) program across a university-based
hospital system can prove challenging to coordinators
responsible for compliance oversight. If a process is designed
without regard to the differences between in-patient,
campus-based, out-patient clinics, and remote off-site provider
offices, it increases the chance that the target or goal will
not be met.
One striking disparity between on- and off-campus sites is how
campus-based services are delivered. An example at our
institution of how distance complicates standardization of POC
across an enterprise is delivery of reagents from a campus
materials department. Another example is the impracticality of
operators traveling to campus for observation check-offs
available to on-campus operators. A third example is
establishing the need for connecting the POC devices in use
across the enterprise.
In light of
the financial burden to connect, what benefits make it worth an
off-site clinic finding the money if they have to fund their
participation? Are there alternative ways to manage a POC
program?
Click here for more >
A Tight Glycemic
Control Initiative
June 2005 • Advance for Administrators of the Lab
• At the Bedside:
By
Nicole Woody, MT(ASCP)
Tight
Glycemic Control (TGC) should qualify as the 2005 phrase of the
year. TGC is everywhere in the health care literature, Web
casts, listservs and continuing education programs. A Google
search of the term yields over 30,000 hits. My experience with
TGC began in November 2004, when a glycemic taskforce convened
to discuss glycemic control in the hospital. The taskforce was
made up of physicians, nurses, dietitians, laboratory
professionals, information services employees and pharmacists.
Four Basic
Groups
The taskforce's first assigned duty was to identify existing
patient safety issues with glycemic control and prioritize those
issues. To accomplish this, the task force was broken into four
work groups. The groups included nursing, laboratory/devices,
dietary and pharmacology. Nursing looked at the various issues
concerning TGC and its impact on the staff. Dietary looked at
the food we were serving our patients. Pharmacology looked at
many issues, including the types of insulin we use and dextrose
concentrations used for intravenous drips. Finally, the
laboratory/devices group looked at our existing point-of-care (POC)
glucose testing meters, who uses the meters, staff education and
the number of meters in use.
The first
phase of the task force went relatively well. There were
meetings every other week to discuss and work through the issues
that arose. A protocol was developed for use in the
Cardiothoracic Surgical Intensive Care Unite (CT SICU) and its
related step-down unit. Unfortunately, everyone wanted TGC to
work without looking at the reality of the protocol.
Click here for more >
POCT Compliance with JCAHO's National Patient Safety Goals
Point of Care:
The Journal of Near-Patient Testing & Technology:
Vol 4(2)
June 05,
Ehrmeyer, Sharon S PhD, MT(ASCP); Darcy, Teresa P
MD, MMM.
Today, ensuring
patient safety through error prevention is a priority for
healthcare organizations. In response to the Institute of
Medicine report that 98,000 deaths annually in US hospitals
result from preventable medical errors, the Joint Commission on
Accreditation of Healthcare Organizations (JCAHO) disseminated
its first national patient safety goals (NPSG).
On January 1,
2005, JCAHO began surveying accredited healthcare organizations
for implementation of applicable 2005 goals and requirements. It
is essential that point of care testing (POCT) sites in the
approximately 4500 US hospitals accredited by the JCAHO
understand these goals and create the necessary policies and
procedures for achieving them. This report addresses the
relevant NPSG identified by JCAHO for its Laboratory Program and
a total quality management strategy for POCT to follow to ensure
compliance with the relevant goals.
For 2005
JCAHO identified 12 NPSG for its 10 healthcare programs. These
programs are ambulatory care and office-based surgery, assisted
living, behavioral health care, critical access hospital,
disease-specific care, home care, hospital, laboratory, long
term care, and networks (integrated delivery systems, managed
care and preferred provider organizations).
Click here > for
the rest of this article.
Access does require a subscription to
Point of Care: The
Journal of Near-Patient Testing & Technology.
POC Connectivity Takes
Hold
CAP Today, June 2005,
Feature Story, by
Anne Paxton
Point-of-care testing
connectivity presents POC coordinators with a dilemma:
Should they let other hospitals be the early adopters while the
bugs are ironed out? Or should they rush to take advantage of
the streamlined, comprehensive data capture that connectivity
has to offer?
Both choices have their pluses and
minuses, but point-of-care testing coordinators who have taken
the leap into POC connectivity say once they got past the
learning curve blues, the payoff was worth it. With the array of
POC vendors and diverse analytical profiles, POC data can’t be
handled by the laboratory information system or HIS without a
local data-management system that connects them on a single
platform.
Helped by the industry-wide POC
connectivity standard approved in 2001, POC data-management
systems are gaining a foothold in the nation’s hospitals, but
obstacles remain before point-of-care results glide swiftly,
seamlessly, and accurately into hospital records.
Connectivity solutions from
Abbott POC (PrecisionWeb), Lifescan (Datalink), Medical
Automation Systems (RALS), Telcor (QML) are referenced
throughout this article.
Click here for more >
Glucose Testing Variability and
the Need for an Expert Oversight Committee
CAP
Today, May 2005, Feature Story,
Joyce G.
Schwartz, MD, Samuel B. Reichberg, MD, PhD
Raymond S. Gambino, MD
In 1979 a work group of the
National Diabetes Data Group1
established the criteria, later endorsed by the World Health
Organization Committee on Diabetes, that patients with a fasting
or 2-h postprandial glucose concentration greater than 140 or 200
mg/dL, respectively, were to be considered diabetic.
In 1997, the Expert Committee
on the Diagnosis and Classification of Diabetes Mellitus was
convened to reexamine the classification and diagnostic criteria
for diabetes based on the 1979 publication of the National
Diabetes Data Group. As a result of its deliberations, the
committee recommended several changes to the diagnostic criteria
for diabetes and for lesser degrees of impaired glucose
regulation.2
The use of a fasting plasma glucose, or FPG, test for the
diagnosis of diabetes was recommended, and the cut point
separating diabetes from nondiabetes was lowered from a FPG >
140 mg/dL to > 126 mg/dL. This change was based on data
that showed an increase in prevalence and incidence of diabetic
retinopathy beginning approximately at a FPG of 126 mg/dL, as well
as on the desire to reduce the discrepancy that existed in the
number of cases detected by the FPG cut point of > 140 mg/dL
and the 2-h value in the OGTT (2-h plasma glucose) of > 200
mg/dL.
Click here for more >
Improving Patient Care With Blood Gas Connectivity
By
Michael Dalton, Advance for the Administrators of the Lab,
Vol. 14 •Issue
3 • POC Connectivity Concepts
The intensive nature of a critical care environment requires
physicians to respond quickly to the needs of a patient to
accurately diagnose and treat him. In this diminished state of
health, a patient's condition can change rapidly, so a more
efficient system enables a physician to obtain arterial blood gas
results rapidly. This enhanced turnaround of patient information
allows the physician to assess the patient's status and implement
therapeutic measures within a very short timeline.
One way to ensure rapid and accurate
blood gas diagnostic test results is to utilize
point-of-care (POC) instruments in the critical care setting
linked with connectivity management solutions. There are
several ways connectivity in the POC setting can bring real
advantages to hospitals and laboratories and help enrich
patient care in crucial areas such as system efficiency,
patient security, data management and equipment and staff
support. All of these workflow benefits ultimately deliver
improved patient care.
Click here for more
ICUs Tighten Belts on Blood Glucose
Levels
CAP Today, February 2005,
Cover Story
by
William Check, PhD
Tight glycemic control shows growing evidence of improving
morbidity and mortality
As George and Ira
Gershwin famously wrote, "Love is sweeping the country!" including
"All the sexes from Maine to Texas." True, "tight glycemic control
in critically ill patients" doesn't have the instant emotional
appeal that love evokes, but it too has been sweeping the country,
becoming routine in intensive care units from Oregon to
Connecticut and many places in between. And whereas love is often
blamed in song with making people feel blue and brokenhearted,
tight glycemic control actually makes people feel better and live
longer, with some of its strongest health benefits seen in
patients with cardiac conditions.
Most important, growing evidence
indicates that tight glycemic control improves morbidity and
mortality not just in diabetics, but in all critically ill
patients, setting the stage for comprehensive blood glucose
protocols to be adopted in ICUs.
Click here for more >
January
1, 2005
Bringing New POCT Equipment on Board
Advance for the Administrators of the Lab,
Vol. 14, Issue 1 POC Connectivity
Concepts,
by Matthew T.
Patton
When
point-of-care testing (POCT) is to be implemented on a large scale—involving
multiple clinics and units or even multiple hospitals—pre-planning by
multidisciplinary teams is essential. Equally important is to incorporate
instrument vendor expertise into the training process. Involvement at all
levels can help ensure that labs stay in regulatory compliance and remain
competent users of POCT equipment.
Staff
Involvement
When dealing
with quality control for employees new to the instrumentation, Lou Ann Wyer,
MT(ASCP), clinical specialist, POCT/QM, Sentara Laboratory Services, Norfolk,
VA, tells ADVANCE that her facility conducts precision, reportable
range or calibration validation and method comparison studies during the
pre-planning phase. Statistical
analysis is performed on each set of data and the method's
performance is approved prior to implementation.
Click here for the complete
article >
Breaking it Down POCT:
The Salary Dilemma
Advance for
Medical Laboratory Professionals,
Vol. 17, Issue 3, Page 14,
by
Kerri Penno
Point-of-care testing professionals often have a difficult
time obtaining compensation for additional duties.The
scenario is familiar across the healthcare field: lines of
responsibility are blurred, expectations are high and
compensation and recognition decidedly are not.
Point-of-care testing (POCT) professionals are being
stretched too thin and wearing too many hats. POCT
coordinators (POCCs) act more like managers, and some
laboratorians are in charge of more POCT work in addition to
their own responsibilities without any additional
compensation. This
job description and salary discrepancy is generating a buzz
among POCT professionals across the nation.
Click here for more >
November 2004
More Studies
Support
Tight Glycemic
Control in Hospitals
By Kay Downer,
Clinical Laboratory News
For years physicians have known the importance
of controlling blood glucose levels in diabetic patients, but only recently
have they begun to realize its importance in treating critically ill
patients—both those with and without diabetes. In
the past few years, several studies have shown that a range of patient
outcomes can be significantly improved by tight glycemic control, a
process of maintaining blood glucose levels within a narrow target
range via frequent insulin administration.
The
rest of this article can be found in the November 2004 issue of Clinical
Laboratory News. Visit www.aacc.org/cln/default.stm
for more information.
Push for Electronic
Medical Records
Gains Momentum
By Penny Allen,
Clinical Laboratory News
In an executive order last April, President
George W. Bush called for widespread deployment of health information
technology within the next 10 years. Intended to improve health care safety,
quality, efficiency, and coordination between providers in the U.S.,
implementing this technology is a noble but lofty goal considering that the
Healthcare Information and Management Systems Society (HIMSS) reported that
this year only 19% of health care provider organizations have fully
operational electronic medical records (EMRs).
The rest of this article can be found in the
November 2004 issue of Clinical Laboratory News. Visit
www.aacc.org/cln/default.stm
for more information.
October 2004
Making the Connection
By Todd Smith,
Advance for Administrators of the Lab
Amid
the information age where technologies are exploding and prices
are shrinking, there is little excuse for point-of-care testing
that is not interfaced.
Connectivity
is an important and complicated issue in point-of-care testing (POCT).
The basic idea is to replace all manual data entry, but there
still is a lot of manual testing. With non-connected testing, the
operator must manually enter the result and other pertinent data
to get it into the information system.
The aim of
connectivity is to provide all this in an electronic,
instantaneous fashion. But one of the most significant issues
surrounding connectivity is the question of compatibility.The
benefits of interfacing POCT are obvious. All lab testing—whether
it is point of care, central lab, satellite lab, etc.—must be made
part of the medical record. Nearly 40 percent of testing is
performed at the patient's bedside, say experts. With technology
becoming more affordable, more devices bearing wireless capability
and all the networks present in the hospitals, there are numerous
options for connecting devices.
"To do point
of care without interfacing makes no sense at all," says Kenneth
E. Blick, PhD, professor, department of Pathology, University of
Oklahoma Health Sciences Center and Medical Center, Oklahoma City.
"There are no excuses for letting devices proliferate throughout
the hospital and having non-lab people select the devices and use
them in a way that is not very businesslike."
This is only a
small part of this article. The complete story can be found in
the October 2004 issue of Advance for the Administrators of the
Lab, Vol. 13 • Issue 10 • Page 63.
Click here for more >>
September 2004
POCT and the New CMS
Guidelines
By Sue Auxter-Parham, Clinical
Laboratory News
Late last year, the Centers for Medicare and
Medicaid Services (CMS) released “Appendix C, Survey Procedures and
Interpretive Guidelines for Laboratories and Laboratory Services”.
This
300-plus-page resource not only provides a general guide for implementing
CLIA ’88, but also gives clinical labs a new way to approach quality control
(QC).
Check
out the September 2004 issue of Clinical Laboratory News for more on this
story >>
August
2004
Applying Evidence-Based Medicine to Point-of-Care Testing to Improve Medical Care
By Renee DiIulio, CLP,
August 2004
Point-of-care testing (POCT)
has been embraced by a medical community that equates new
technology with better patient care. Providers of medical
care are under pressure to provide care more quickly than in
the past, and many see POCT as a solution to remove patient
bottlenecks.
However, James H. Nichols,
PhD, DABCC, FACB, said there is a proliferation of
misinformation about POCT. Nichols, associate professor of
pathology at Tufts University School of Medicine in Boston
and director of clinical chemistry at Baystate Health System
in Springfield, Mass, gave the keynote address, “Finding
Value at the Bedside: Evidence-Based Practice for POCT,”
at the 20th International Symposium on Critical Care and
Point-of-Care Testing in Wurzburg, Germany. “Faster is
often understood to mean better outcomes without the
research to back this conclusion,” he said.
Evidence-Based
Medicine
(EBM) represents a new age in health care.
Nichols traced medicine’s development through the ages,
from its dawn with humors, astrology, and bloodletting,
through its dark period characterized by belief-based
treatments, into an enlightenment with the discovery of the
pathologic basis of disease, and followed by subsequent
growth with advances in prevention, diagnosis, and
treatment.
Click
here for more >>
August
2004
Optimizing
Point-of-Care Testing
By
Barbara M. Goldsmith, PhD, FACB
POCT
Applications as a Useful Tool for Rapid Laboratory Results
Point-of-care testing is
growing rapidly at an estimated rate of 12 percent to 16
percent per year and is predicted to double by 2005,
becoming a $950 million market. In
1997, the Food and Drug Administration convened an expert
panel to describe future trends in medical device technology
over the next 10 years. The panel identified six
major trend categories. Home and self-care and minimally
invasive procedures were among the six categories, each
having applications in POCT.
POCT is referred to as
laboratory testing performed outside of the clinical
laboratory. It can be performed at the patient's bedside or
in a centralized area within a unit, such as an intensive
care unit. POCT applications include:
-
Testing for emergency diagnosis
(e.g. acute cardiac
syndromes)
-
Treatment and monitoring of existing disease
(e.g. diabetes)
-
Testing in the physician's
office
-
Self-testing
The diversity of testing locations also is
broad, including: acute care settings
-
Ambulances
-
Clinics
-
Schools
-
Drug treatment centers
-
Patients' homes
Click
here for more >>
|
|
|
|